secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lakewood-Amedex Biotherapeutics Inc. (LABT)
CIK:        0002079272
Form:       8-K
Filed at:   2026-04-28T23:59:59+00:00
Accession:  0001213900-26-048553
Event type: leadership
Sentiment:  positive
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Appoints Joseph Tucker to board; $6,000/quarter stock + 33,784 warrants at $10
------------------------------------------------------------------------------

- Dr. Joseph Tucker appointed to Board, effective April 24, 2026, until 2027 annual meeting.
- Compensation: $6,000 per quarter in common stock; granted 33,784 warrants at $10.00, 10-year term.
- Warrants vest in 4 equal tranches: Oct 24, 2026; Apr 24, 2027; Oct 24, 2027; Apr 24, 2028.
- Tucker is CEO of Enveric Biosciences (NASDAQ: ENVB) with over $100M capital raised track record.
- Appointment follows LABT's recent Nasdaq direct listing; Tucker joins Audit, Compensation, Governance committees.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2079272/000121390026048553/0001213900-26-048553-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2079272/000121390026048553/ea0287960-8k_lakewood.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-048553

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer